Rigel Pharmaceuticals
RIGL
#6623
Rank
NZ$1.47 B
Marketcap
NZ$78.12
Share price
-1.85%
Change (1 day)
3.92%
Change (1 year)

EPS for Rigel Pharmaceuticals (RIGL)

EPS in 2026 (TTM): NZ$30.55

According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$32.16. In 2025 the company made an earnings per share (EPS) of NZ$36.84 an increase over its 2024 EPS that were of NZ$1.80.

EPS history for Rigel Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$30.55-17.08%
2025NZ$36.841944.44%
2024NZ$1.80
2022NZ-$6.19240%
2021NZ-$1.82-37.5%
2020NZ-$2.91-60%
2019NZ-$7.28-11.11%
2018NZ-$8.19-26.23%
2017NZ-$11.10-17.57%
2016NZ-$13.4725.42%
2015NZ-$10.74-42.72%
2014NZ-$18.75
2012NZ-$24.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
NZ$31.63-1.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$12.96-59.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
NZ-$0.69-102.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
NZ-$3.44-110.70%๐Ÿ‡บ๐Ÿ‡ธ USA